Alzheimer's drug adoption in US slowed by doctors' skepticism Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle to widespread use: an entrenched belief among ... 04/23/2024 - 5:26 am | View Link